25.07.2017 | Translational Research and Biomarkers | Ausgabe 13/2017

Expression of 3β-Hydroxysteroid Dehydrogenase Type 1 in Breast Cancer is Associated with Poor Prognosis Independent of Estrogen Receptor Status
- Zeitschrift:
- Annals of Surgical Oncology > Ausgabe 13/2017